Skip to main content

Transforming the understanding
and treatment of mental illnesses.

Celebrating 75 Years! Learn More >>

NAMHC’s Drug Development Workgroup Roster

| Charge |

Co-Chairs

Kalpana M. Merchant, Ph.D.
President and Chief Scientific Officer
Trans Thera Consulting
Portland, OR

John H. Krystal, M.D.
Robert L. McNeil, Jr, Professor of Translational Research
Professor of Psychiatry, Neuroscience, and Psychology
Chair, Department of Psychiatry
Yale University
Chief of Psychiatry and Behavioral Science
Yale-New Haven Health
New Haven, CT

Members

Anissa Abi-Dargham, M.D.
Lourie Endowed Chair in Psychiatry
Professor of Psychiatry and Radiology and Vice Chair for Research, Department of Psychiatry
Director, Multi Modal Translational Imaging Lab
Associate Dean for Clinical and Translational Science
Stony Brook University, Renaissance School of Medicine
Stony Brook, NY

Deanna Barch, Ph.D.
Gregory B. Couch Professor of Psychiatry
Department of Psychology, Psychiatry and Radiology
Washington University
St. Louis, MO

Danny Benjamin, M.D., Ph.D.
Kiser-Arena Distinguished Professor of Pediatrics
Chair, Pediatric Trials Network
Deputy Director, Duke Clinical Research Institute
Duke University
Durham, NC

Edward T. Bullmore, FRCP, FRCPsych
Professor
Head, Department of Psychiatry
Behavioral and Clinical Neuroscience Institute
Cambridge University
Cambridge, UK

Carla Canuso, M.D.
Vice President of Neuroscience Clinical Development
Janssen Research & Development, LLC
New Brunswick, NJ

Michael Davis, M.D., Ph.D.
Clinical Team Leader
U.S. Food and Drug Administration
Division of Psychiatry
Office of New Drugs
Silver Spring, MD

Michael Ehlers, M.D., Ph.D.
Chief Scientific Officer, Venture Partner
Apple Tree Partners
Cambridge, MA

Raquel E. Gur, M.D., Ph.D.
The Karl and Linda Rickels Professor
Director, Neurodevelopment and Psychosis Section
Professor Departments of Psychiatry, Neurology & Radiology 
Sr Vice Chair for Res. & Penn-CHOP Research Integration
Director, Lifespan Brain Institute, CHOP & Penn Medicine
Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA

John Isaac, Ph.D.
Janssen Neuroscience,
Johnson & Johnson
London, UK

Hartmuth C. Kolb, Ph.D.
Vice President
Neuroscience Biomarkers
Janssen R&D Global Imaging
Johnson & Johnson
San Diego, CA

Donald C. Lo, Ph.D.
Director
Therapeutic Development Branch
National Center for Advancing Translational Sciences
National Institutes of Health
Rockville, MD

Sanjay J. Mathew, M.D.
Marjorie Bintliff Johnson and Raleigh White Johnson, Jr. Vice Chair for Research
Professor of Psychiatry and Behavioral Sciences
Menninger Department of Psychiatry & Behavioral Sciences
Baylor College of Medicine
Houston, TX

Kurt Rasmussen, Ph.D.
Director
Division of Therapeutics and Medical Consequences
National Institute on Drug Abuse
Bethesda, MD

Piet van der Graaf, PharmD, Ph.D.
Senior Vice President, Quantitative Systems Pharmacology
Professor of Systems Pharmacology
Certara
Canterbury, UK

Sophia Vinogradov, M.D.
Donald W. Hastings Endowed Chair
University of Minnesota Medical School
Professor and Department Head
Department of Psychiatry
Minneapolis, MN

NIMH Staff

Jamie Driscoll
Program Officer
Signal Transduction Program
Office of Research Training and Career Development
Division of Neuroscience and Basic Behavioral Science
National Institute of Mental Health
Rockville, MD

Jovier Evans, Ph.D.
Chief
Geriatrics and Aging Processes Research Branch
Neuroscience of Mental Disorders and Aging Program
Division of Translational Research
National Institute of Mental Health
Rockville, MD

Margaret Grabb, Ph.D.
Program Officer, Novel Pharmacologic and Device-based Intervention Program for Pediatrics and SBIR/STTR Coordinator
Division of Neuroscience and Basic Behavioral Science
Division of Translational Research
National Institute of Mental Health
Rockville, MD

Mi Hillefors, M.D., Ph.D.
Acting Deputy Director
Division of Translational Research
Chief, Translational Therapeutics Program,
Adult Pathophysiology and Biological Interventions Development Branch
National Institute of Mental Health
Rockville, MD

Rebecca Wagenaar-Miller, Ph.D.
Chief
Extramural Policy Branch
Division of Extramural Activities
National Institute of Mental Health
Rockville, MD

Jean Noronha, Ph.D.
Director
Division of Extramural Activities
National Institute of Mental Health
Rockville, MD

Matthew Rudorfer, M.D.
Chief
Somatic Treatments and Psychopharmacology Branch
Treatment and Preventive Interventions Research Branch
Division of Services and Intervention Research
National Institute of Mental Health
Rockville, MD

Jeffrey Seeburger, Ph.D.
Consultant
Office of the Director
National Institute of Mental Health
Rockville, MD